JPWO2020076790A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020076790A5
JPWO2020076790A5 JP2021519609A JP2021519609A JPWO2020076790A5 JP WO2020076790 A5 JPWO2020076790 A5 JP WO2020076790A5 JP 2021519609 A JP2021519609 A JP 2021519609A JP 2021519609 A JP2021519609 A JP 2021519609A JP WO2020076790 A5 JPWO2020076790 A5 JP WO2020076790A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021519609A
Other languages
English (en)
Japanese (ja)
Other versions
JP7459075B2 (ja
JP2022512646A5 (https=
JP2022512646A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055144 external-priority patent/WO2020076790A1/en
Publication of JP2022512646A publication Critical patent/JP2022512646A/ja
Publication of JPWO2020076790A5 publication Critical patent/JPWO2020076790A5/ja
Publication of JP2022512646A5 publication Critical patent/JP2022512646A5/ja
Application granted granted Critical
Publication of JP7459075B2 publication Critical patent/JP7459075B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021519609A 2018-10-09 2019-10-08 スタフィロコッカス・アウレウス(Staphylococcus aureus)ロイコトキシンに対して向けられた抗体 Active JP7459075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743501P 2018-10-09 2018-10-09
US62/743,501 2018-10-09
PCT/US2019/055144 WO2020076790A1 (en) 2018-10-09 2019-10-08 Antibodies directed against staphylococcus aureus leukotoxins

Publications (4)

Publication Number Publication Date
JP2022512646A JP2022512646A (ja) 2022-02-07
JPWO2020076790A5 true JPWO2020076790A5 (https=) 2022-10-18
JP2022512646A5 JP2022512646A5 (https=) 2022-10-18
JP7459075B2 JP7459075B2 (ja) 2024-04-01

Family

ID=68393067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519609A Active JP7459075B2 (ja) 2018-10-09 2019-10-08 スタフィロコッカス・アウレウス(Staphylococcus aureus)ロイコトキシンに対して向けられた抗体

Country Status (11)

Country Link
US (2) US11059884B2 (https=)
EP (1) EP3864040A1 (https=)
JP (1) JP7459075B2 (https=)
KR (1) KR20210080411A (https=)
CN (1) CN113015745B (https=)
AU (1) AU2019359207A1 (https=)
BR (1) BR112021006704A2 (https=)
CA (1) CA3115765A1 (https=)
MX (1) MX2021004114A (https=)
TW (1) TWI895248B (https=)
WO (1) WO2020076790A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX375324B (es) * 2012-11-06 2025-03-06 Medimmune Llc Anticuerpos contra determinantes de la superficie de s. aureus.
TWI902669B (zh) 2018-07-24 2025-11-01 美商麥迪紐有限責任公司 抗金黃色葡萄球菌凝集因子a(clfa)之抗體
MX2021004114A (es) 2018-10-09 2021-07-16 Medimmune Llc Anticuerpos dirigidos contra leucotoxinas de staphylococcus aureus.
CN113164602A (zh) 2018-10-09 2021-07-23 免疫医疗有限责任公司 抗金黄色葡萄球菌抗体的组合
CN113811544A (zh) 2019-03-13 2021-12-17 免疫医疗有限责任公司 减少定殖患者中的金黄色葡萄球菌感染
CN113583119B (zh) * 2021-07-07 2023-05-02 西北农林科技大学 抗金黄色葡萄球菌的纳米抗体Nb56、应用及试剂盒
CN113493510A (zh) * 2021-07-07 2021-10-12 上海交通大学 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658921B2 (en) 2000-12-12 2010-02-09 Medimmune, Llc Molecules with extended half-lives, compositions and uses thereof
MXPA05000511A (es) 2001-07-12 2005-09-30 Jefferson Foote Anticuepros super humanizados.
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
BRPI0807952A2 (pt) 2007-02-20 2014-06-10 Anaptysbio Inc Sistemas de hipermutação somática
CN104119438A (zh) 2009-01-29 2014-10-29 米迪缪尼有限公司 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用
RU2677140C1 (ru) * 2010-05-05 2019-01-15 Нью-Йорк Юниверсити Лейкоцидины staphylococcus aureus, терапевтические композиции и их применение
EP3470526A3 (en) 2011-02-08 2019-07-17 Medimmune, LLC Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
US9845348B2 (en) 2012-11-06 2017-12-19 Medimmune, Llc Methods of treating S. aureus-associated diseases
MX375324B (es) 2012-11-06 2025-03-06 Medimmune Llc Anticuerpos contra determinantes de la superficie de s. aureus.
EP3057989A1 (en) 2013-10-17 2016-08-24 ARSANIS Biosciences GmbH Cross-reactive staphylococcus aureus antibody sequences
EP3142700B1 (en) 2014-05-16 2021-03-03 Medimmune, LLC Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
TWI719938B (zh) 2014-06-19 2021-03-01 美商麥迪紐有限責任公司 多重細菌感染之治療
MX2017012775A (es) 2015-04-17 2019-04-29 Arsanis Biosciences Gmbh Preparacion combinatoria de anticuerpos anti-staphylococcus aureus.
US20190077851A1 (en) 2015-10-30 2019-03-14 Bruno Francois Methods of using anti-alpha toxin antibody
TWI902669B (zh) 2018-07-24 2025-11-01 美商麥迪紐有限責任公司 抗金黃色葡萄球菌凝集因子a(clfa)之抗體
CN113164602A (zh) 2018-10-09 2021-07-23 免疫医疗有限责任公司 抗金黄色葡萄球菌抗体的组合
MX2021004114A (es) 2018-10-09 2021-07-16 Medimmune Llc Anticuerpos dirigidos contra leucotoxinas de staphylococcus aureus.

Similar Documents

Publication Publication Date Title
JP2021105034A5 (https=)
JP2021530244A5 (https=)
RU2012112340A (ru) Гуманизированные моноклональные антитела к сеа с созревшей аффинностью
JP2019205480A5 (https=)
JP2024105229A5 (https=)
CN113015745A (zh) 针对金黄色葡萄球菌白细胞毒素的抗体
JP2017507131A5 (https=)
JP2020522488A5 (https=)
CN109721656B (zh) 靶向rankl的治疗性抗体
JP2024001073A5 (https=)
JP2021511387A5 (https=)
JP2022528387A (ja) アビド結合多重特異性抗体を作製する方法
JPWO2020076790A5 (https=)
JP2021155416A5 (https=)
JPWO2022111425A5 (https=)
JPWO2020023644A5 (https=)
JP7821161B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
JPWO2021233834A5 (https=)
JP2021518748A5 (https=)
JPWO2021133723A5 (https=)
JPWO2020028428A5 (https=)
JPWO2020076789A5 (https=)
JP2021514369A5 (https=)
JPWO2023129928A5 (https=)
RU2021111775A (ru) Антитела, направленные против лейкотоксинов staphylococcus aureus